Maryland Capital Management Eli Lilly & CO Transaction History

Maryland Capital Management

$1.2 Billion
Q3 2022

A detailed history of Maryland Capital Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Maryland Capital Management holds 9,694 shares of LLY stock, worth $7.94 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

9,694

Previous 9,614 0.83%

Holding current value

$7.94 Million

Previous $3.12 Million 0.58%

% of portfolio

0.26%

Previous 0.25%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $23,718 - $27,029	80 Added 0.83%	9,694 $3.14 Million
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $169,746 - $199,307	-609 Reduced 5.96%	9,614 $3.12 Million
Q1 2022 May 12, 2022	SELL	$234.69 - $291.66 $1.15 Million - $1.43 Million	-4,914 Reduced 32.46%	10,223 $2.93 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $232,494 - $288,527	-1,034 Reduced 6.39%	15,137 $4.18 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $3.64 Million - $4.47 Million	-16,408 Reduced 50.36%	16,171 $3.74 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $1.27 Million - $1.64 Million	-7,037 Reduced 17.76%	32,579 $7.48 Million
Q1 2021 May 11, 2021	BUY	$164.32 - $212.72 $104,178 - $134,864	634 Added 1.63%	39,616 $7.4 Million
Q4 2020 Feb 11, 2021	BUY	$130.46 - $172.63 $517,012 - $684,132	3,963 Added 11.32%	38,982 $6.58 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $141,394 - $163,548	967 Added 2.84%	35,019 $5.18 Million
Q2 2020 Aug 12, 2020	SELL	$136.42 - $164.18 $86,763 - $104,418	-636 Reduced 1.83%	34,052 $5.59 Million
Q1 2020 May 13, 2020	BUY	$119.05 - $147.35 $220,123 - $272,450	1,849 Added 5.63%	34,688 $4.81 Million
Q4 2019 Feb 11, 2020	BUY	$106.92 - $132.43 $138,247 - $171,231	1,293 Added 4.1%	32,839 $4.32 Million
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $82,762 - $90,024	775 Added 2.52%	31,546 $3.53 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $354,638 - $413,953	-3,201 Reduced 9.42%	30,771 $3.41 Million
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $109,417 - $128,792	-983 Reduced 2.81%	33,972 $4.41 Million
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $247,276 - $277,024	2,335 Added 7.16%	34,955 $4.05 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $78,561 - $98,188	-915 Reduced 2.73%	32,620 $3.5 Million
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $757 - $868	-10 Reduced 0.03%	33,535 $2.86 Million
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $742 - $876	10 Added 0.03%	33,545 $2.6 Million
Q4 2017 Feb 13, 2018	SELL	$81.94 - $87.89 $43,837 - $47,021	-535 Reduced 1.57%	33,535 $2.83 Million
Q3 2017 Nov 14, 2017	SELL	$77.07 - $85.54 $1,926 - $2,138	-25 Reduced 0.07%	34,070 $2.91 Million
Q2 2017 Aug 14, 2017	BUY	N/A	34,095	34,095 $2.81 Million

Others Institutions Holding LLY

# of Institutions

3,912

Shares Held

765M

Call Options Held

6.35M

Put Options Held

7.96M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $778B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Maryland Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Maryland Capital Management with notifications on news.

Account

Maryland Capital Management Eli Lilly & CO Transaction History